Interestingly, AOX1 converts 5-hydroxyindoleacetaldehyde to 5-hydroxyindoleacetate, which is a significantly down-regulated metabolite in metastatic prostate cancers compared to primary tumor samples (Figure S6) [41]. Here, AOX1 is linked to neoplasm.